Free Trial
NYSEAMERICAN:CTEK

CynergisTek (CTEK) Stock Price, News & Analysis

CynergisTek logo
$1.25 +0.02 (+1.63%)
(As of 08/31/2022)

About CynergisTek Stock (NYSEAMERICAN:CTEK)

Key Stats

Today's Range
$1.23
$1.25
50-Day Range
N/A
52-Week Range
$0.58
$2.04
Volume
167,600 shs
Average Volume
293,474 shs
Market Capitalization
$16.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CynergisTek, Inc. provides cyber security, privacy, and compliance services in the United States. The company identifies, measures, and tests security and privacy risk of organization, as well as verifies and validates their programs to meet compliance and business objectives through IT audits, technical testing, and risk and program assessments; develops policies, procedures, and playbooks to help build out a risk management program; and verifies the processes, people, and technology are working effectively. It also provides insights to the ROI of an organization's security investment; resources to help organizations prioritize, implement, and execute initiatives to strengthen their security and privacy programs; and on-going management and oversight organization's security and privacy programs to address or give alerts when an issue arises. It serves primarily in the healthcare industry, as well as education, financial services, government, internet and media, and manufacturing industries under the CynergisTek, Redspin, and Backbone Consulting brands. The company was formerly known as Auxilio, Inc. and changed its name to CynergisTek, Inc. in September 2017. CynergisTek, Inc. was incorporated in 1995 and is based in Austin, Texas.

Receive CTEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CynergisTek and its competitors with MarketBeat's FREE daily newsletter.

CTEK Stock News Headlines

Save Money This Winter
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
CTEK Battery Care Kits Custom Designed for Builders
See More Headlines

CTEK Stock Analysis - Frequently Asked Questions

CynergisTek, Inc. (NYSEAMERICAN:CTEK) released its earnings results on Thursday, November, 11th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.22. The company had revenue of $3.83 million for the quarter. CynergisTek had a negative trailing twelve-month return on equity of 42.78% and a negative net margin of 61.80%.

Shares of CTEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that CynergisTek investors own include Corbus Pharmaceuticals (CRBP), BIOLASE (BIOL), Carnival Co. & (CCL), Peabody Energy (BTU), Dynavax Technologies (DVAX), General Electric (GE) and Kinross Gold (KGC).

Company Calendar

Last Earnings
11/11/2021
Today
11/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Business Services
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:CTEK
Previous Symbol
NYSEMKT:CTEK
Employees
89
Year Founded
N/A

Profitability

Net Income
$-2,250,000.00
Pretax Margin
-30.59%

Debt

Sales & Book Value

Annual Sales
$16.30 million
Book Value
$1.15 per share

Miscellaneous

Free Float
11,852,000
Market Cap
$16.57 million
Optionable
Not Optionable
Beta
1.25
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NYSEAMERICAN:CTEK) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners